Glenn Welling Engaged Capital
Glenn Welling is the founder of Engaged Capital, an activist investment firm focused primarily on small- and mid-cap U.S. companies. Engaged Capital seeks undervalued businesses where operational improvement, cost discipline, or strategic change can unlock value. Welling’s campaigns are closely watched in the activist community for mid-market corporate engagement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hain Celestial
HAIN
|
+$51.1M |
| 2 |
FNSR
Finisar Corp
FNSR
|
+$47.9M |
| 3 |
Apogee Enterprises
APOG
|
+$27.7M |
| 4 |
PETX
Aratana Therapeutics, Inc.
PETX
|
+$8.92M |
| 5 |
Benchmark Electronics
BHE
|
+$4.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medifast
MED
|
+$18.5M |
| 2 |
IMAX
IMAX
|
+$4.3M |
| 3 |
NCR Voyix
VYX
|
+$3.79M |
| 4 |
Babcock & Wilcox
BW
|
+$3.55M |
| 5 |
Magnachip Semiconductor
MX
|
+$3.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 57.71% |
| 2 | Technology | 25.29% |
| 3 | Industrials | 11.33% |
| 4 | Consumer Discretionary | 3.3% |
| 5 | Healthcare | 1.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Hain Celestial
HAIN
$71.6M
| $377M | 51.2% |
11,761,242
+1,407,543
| +14% | +$51.1M |
|
2
Upbound Group
UPBD
$1.1B
| $77.5M | 10.52% |
8,983,609
| – | – |
|
|
STKL
3
DELISTED
SunOpta
STKL
| $48M | 6.51% |
6,756,907
| – | – |
|
|
4
Apogee Enterprises
APOG
$868M
| $43.3M | 5.88% |
998,934
+620,767
| +164% | +$27.7M |
|
|
FNSR
5
DELISTED
Finisar Corp
FNSR
| $40.1M | 5.45% |
+2,538,126
| New | +$47.9M |
|
|
TIVO
6
DELISTED
Tivo Inc
TIVO
| $34.2M | 4.64% |
2,525,000
| – | – |
|
|
7
Benchmark Electronics
BHE
$2.61B
| $32.6M | 4.43% |
1,092,710
+141,248
| +15% | +$4.24M |
|
|
JMBA
8
DELISTED
Jamba, Inc.
JMBA
| $24.3M | 3.3% |
2,834,002
| – | – |
|
9
Celestica
CLS
$37.4B
| $17.1M | 2.32% |
1,652,439
-166,701
| -9% | -$1.79M |
|
|
10
Magnachip Semiconductor
MX
$121M
| $11.3M | 1.54% |
1,181,225
-300,000
| -20% | -$3.17M |
|
|
PETX
11
DELISTED
Aratana Therapeutics, Inc.
PETX
| $8.82M | 1.2% |
+2,000,000
| New | +$8.92M |
|
|
12
NCR Voyix
VYX
$1.09B
| $7.6M | 1.03% |
393,081
-179,810
| -31% | -$3.79M |
|
|
13
Babcock & Wilcox
BW
$1.23B
| $5.94M | 0.81% |
135,833
-61,188
| -31% | -$3.55M |
|
|
CCRN
14
DELISTED
Cross Country Healthcare
CCRN
| $5.46M | 0.74% |
491,669
| – | – |
|
15
iShares Russell 2000 ETF
IWM
$81.9B
| $3.19M | 0.43% |
21,000
-4,200
| -17% | -$649K |
|
|
16
IMAX
IMAX
$2.89B
| – | – |
-185,814
| Closed | -$4.3M |
|
|
17
Medifast
MED
$134M
| – | – |
-264,549
| Closed | -$18.5M |
|
Similar funds
Glenn Welling's Q1 2018 Portfolio in Review
As of Q1 2018, Glenn Welling held 17 positions worth $737M, down 6.5% from $788M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Glenn Welling deployed $104M of net new capital in Q1 2018, opening 2 new positions and adding to 3 existing holdings. Its largest new stake was Finisar Corp: 2,538,126 shares worth $40.1M.
By sector, the portfolio is most concentrated in Consumer Staples at 58% of assets, down from 62% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was NCR Voyix, an estimated $3.79M trimmed.
- Glenn Welling's largest Q1 2018 buy was Finisar Corp: 2,538,126 shares worth $40.1M.
- Glenn Welling added most to Hain Celestial in Q1 2018, an estimated $51.1M increase.
- Glenn Welling's biggest Q1 2018 reduction was NCR Voyix, cutting an estimated $3.79M.
- Glenn Welling fully exited Medifast in Q1 2018, selling an estimated $18.5M.
- Glenn Welling's ten largest holdings make up 96% of its $737M portfolio in Q1 2018.
- Glenn Welling opened 2 new positions and closed 2 in Q1 2018.
- Glenn Welling's portfolio value fell 6.5% quarter-over-quarter to $737M.
Based on Engaged Capital's 13F filing for Q1 2018, filed 15 May 2018.